作者：
Ciuleanu, T. [1]
;
Bazin, I. [2]
;
Lungulescu, D. [3]
;
Miron, L. [4]
;
Bondarenko, I. [5]
;
Deptala, A. [6]
;
Rodriguez-Torres, M. [7]
;
Giantonio, B. [8]
;
Fox, N. L. [9]
;
Wissel, P. [10]
;
Egger, J. [11]
;
Ding, M. [12]
;
Kalyani, R. N. [13]
;
Humphreys, R. [14]
;
Gribbin, M. ;
Sun, W.
作者单位：
Russian Acad Med Sci, Russian Oncol Res Ctr, Fed State Budgetary Inst, Moscow, Russia
[1]
GlaxoSmithKline, Clin Dev, Upper Providence, PA USA
[2]
GlaxoSmithKline, Clin Dev, Stockley Pk, Middx, England
[3]
CSK MSW, Dept Oncol & Hematol, Warsaw, Poland
[4]
Univ Penn, Abramson Canc Ctr, Dept Hematol Oncol, Philadelphia, PA 19104 USA
[5]
City Multispecial Clin Hosp 4, Dnipropetrovsk Med Acad, Dept Oncol & Med Radiol, Dnepropetrovsk
[6]
Fdn Invest, San Juan, PR USA
[7]
Iasi Reg Inst Oncol, Iasi, Iasi County, Romania
[8]
Prof Dr Ion Chiricuta Inst Oncol, Dept Med Oncol, 34-36 Republicii St, Cluj Napoca 400015, Romania
[9]
Human Genome Sci Inc, Clin Dev, Rockville, MD USA
[10]
GlaxoSmithKline, Stat, Upper Providence, Middx, England
[11]
SC Oncolab SRL, Craiova, Dolj County, Romania
[12]
Human Genome Sci Inc, Stat, Rockville, MD USA
[13]
Human Genome Sci Inc, Oncol Res, Rockville, MD USA
[14]
发布时间
2017-04-05
换一批
